FDA Finds Drug Co. Clinical Tests Lack Diversity
Racial minorities tend to be underrepresented in clinical trials of drugs and devices, but that doesn't appear to be compromising the results of such testing, the U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article